Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Subramanian, V; Sauguet, A; Werner, M; Sbarzaglia, P; Hausegger, KA; Goyault, G; Guerra, M; Deloose, K; Kahlberg, A; Balestriero, G; Brodmann, M; Binkert, C; Goueffic, Y; Groezinger, G; Schwindt, A; Schlager, O; Bertoglio, L; Adams, G; Sultana, N; Coscas, R.
Radial access for peripheral vascular intervention: the S.M.A.R.T. RADIANZ Vascular Stent System.
Expert Rev Med Devices. 2023; 1-6 Doi: 10.1080/17434440.2023.2240227
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Brodmann Marianne
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: INTRODUCTION: Radial access is the standard of care for nearly all cardiac catheterization procedures. It improves patient satisfaction, reduces the length of stay, and is associated with fewer complications. However, few devices and tools are available for the treatment of peripheral arterial disease via a transradial approach (TRA). The S.M.A.R.T. RADIANZ Vascular Stent System is among the RADIANZ suite of products, which is aimed at expanding the portfolio of devices to treat peripheral arterial disease. AREAS COVERED: In this Expert review, the following areas will be covered: (1) Current Landscape of peripheral vascular intervention (PVI) using TRA (2) Detailed description of the S.M.A.R.T. RADIANZ Vascular Stent System. (3) Ongoing clinical trials to evaluate safety of this approach. (4) Future directions and current regulatory status. EXPERT OPINION: TRA for PVI is a promising approach. It holds the possibility of substantially improving the care of patients with peripheral arterial disease (PAD). Numerous challenges must be overcome to realize the full potential of a radial-to-peripheral (RTP) approach. The length of devices and the small sheath size are the main constraints of this approach. The results of the ongoing RADIANCY trial will demonstrate the safety, in selected patients, of the RADIANZ suite of products.
Find related publications in this database (Keywords): Radial-to-peripheral; iliac artery disease; femoropopliteal artery disease; endovascular intervention; transradial access; >